A M Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 726.12%
- Profit Growth 2967.45%
- Ebitda 2181.55%
- Net Worth 517.45%
- Total Assets 848.31%
About A M Pharmaceuticals (India)
A M Pharmaceuticals (India) Private Limited (AMPIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 May 2010 and has a history of 14 years and eight months. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shameem Majeed, Arun Majeed, and Abdul Hameed serve as directors at the Company.
Company Details
-
Location
Thrissur, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233KL2010PTC026018
-
Company No.
026018
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 May 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at A M Pharmaceuticals (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abdul Hameed
|
Managing Director | 15-Apr-2024 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shameem Majeed
|
Director | 17-May-2010 | Current |
|
Arun Majeed
|
Director | 17-May-2010 | Current |
Financial Performance of A M Pharmaceuticals (India).
A M Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 726.12% increase. The company also saw a substantial improvement in profitability, with a 2967.45% increase in profit. The company's net worth Soared by an impressive increase of 517.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A M Pharmaceuticals (India)?
In 2022, A M Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Yungage Developers Private LimitedShameem Majeed, Arun Majeed and 1 more are mutual person
-
Deoscent Developers Private Limited
Shameem Majeed, Arun Majeed and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at A M Pharmaceuticals (India)?
A M Pharmaceuticals (India) has a workforce of 260 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A M Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A M Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.